Do analysts recommend MXCT or NIOX?

NIOX Group has a consensus price target of GBX 86, indicating a potential upside of 49.93%. Given NIOX Group's stronger consensus rating and higher probable upside, analysts clearly believe NIOX Group is more favorable than MaxCyte. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MaxCyte 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 NIOX Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has better earnings & valuation, MXCT or NIOX?

NIOX Group has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MaxCyte £32.29M 0.04 -£45.08M -£40.00 N/A NIOX Group £48.70M 4.96 £995.88M £1.64 34.98

Is MXCT or NIOX more profitable?

NIOX Group has a net margin of 14.37% compared to MaxCyte's net margin of -119.69%. NIOX Group's return on equity of 10.14% beat MaxCyte's return on equity. Company Net Margins Return on Equity Return on Assets MaxCyte -119.69% -11.59% -11.07% NIOX Group 14.37% 10.14% 3.95%

Do analysts rate IUG or NIOX?

NIOX Group has a consensus price target of GBX 86, indicating a potential upside of 49.93%. Given NIOX Group's stronger consensus rating and higher probable upside, analysts plainly believe NIOX Group is more favorable than Intelligent Ultrasound Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Ultrasound Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 NIOX Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts recommend NIOX or NCYT?

NIOX Group presently has a consensus target price of GBX 86, suggesting a potential upside of 49.93%. Given NIOX Group's stronger consensus rating and higher possible upside, research analysts clearly believe NIOX Group is more favorable than Novacyt. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NIOX Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Novacyt 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, NIOX or NCYT?

NIOX Group has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NIOX Group £48.70M 4.96 £995.88M £1.64 34.98 Novacyt £20.03M 1.27 -£36.80M -£32.00 N/A

Is NIOX or NCYT more profitable?

NIOX Group has a net margin of 14.37% compared to Novacyt's net margin of -103.08%. NIOX Group's return on equity of 10.14% beat Novacyt's return on equity. Company Net Margins Return on Equity Return on Assets NIOX Group 14.37% 10.14% 3.95% Novacyt -103.08% -96.44% -27.98%

NIOX Group (NIOX) Competitors

GBX 57.36 -0.44 (-0.76%)

As of 07/13/2026 12:03 PM Eastern

Compare

NIOX vs. MXCT, EKF, CREO, IUG, and NCYT

Should you buy NIOX Group stock or one of its competitors? MarketBeat compares NIOX Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NIOX Group include MaxCyte (MXCT), EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), and Novacyt (NCYT). These companies are all part of the "medical devices" industry.

How does NIOX Group compare to MaxCyte?

MaxCyte (LON:MXCT) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

MaxCyte has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market.

NIOX Group has a net margin of 14.37% compared to MaxCyte's net margin of -119.69%. NIOX Group's return on equity of 10.14% beat MaxCyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MaxCyte	-119.69%	-11.59%	-11.07%
NIOX Group	14.37%	10.14%	3.95%

24.0% of MaxCyte shares are owned by institutional investors. Comparatively, 7.6% of NIOX Group shares are owned by institutional investors. 1.9% of MaxCyte shares are owned by company insiders. Comparatively, 5.1% of NIOX Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

NIOX Group has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MaxCyte	£32.29M	0.04	-£45.08M	-£40.00	N/A
NIOX Group	£48.70M	4.96	£995.88M	£1.64	34.98

NIOX Group has a consensus price target of GBX 86, indicating a potential upside of 49.93%. Given NIOX Group's stronger consensus rating and higher probable upside, analysts clearly believe NIOX Group is more favorable than MaxCyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MaxCyte	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, MaxCyte's average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.

Company	Overall Sentiment
MaxCyte	Neutral
NIOX Group	Neutral

Summary

NIOX Group beats MaxCyte on 12 of the 14 factors compared between the two stocks.

How does NIOX Group compare to EKF Diagnostics?

EKF Diagnostics (LON:EKF) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

In the previous week, EKF Diagnostics' average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.

Company	Overall Sentiment
EKF Diagnostics	Neutral
NIOX Group	Neutral

NIOX Group has lower revenue, but higher earnings than EKF Diagnostics. NIOX Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EKF Diagnostics	£51.56M	2.19	£4.68M	£0.47	55.96
NIOX Group	£48.70M	4.96	£995.88M	£1.64	34.98

EKF Diagnostics has a beta of 0.513, suggesting that its share price is 49% less volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market.

NIOX Group has a net margin of 14.37% compared to EKF Diagnostics' net margin of 4.12%. NIOX Group's return on equity of 10.14% beat EKF Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EKF Diagnostics	4.12%	3.01%	5.27%
NIOX Group	14.37%	10.14%	3.95%

EKF Diagnostics currently has a consensus price target of GBX 35, indicating a potential upside of 33.08%. NIOX Group has a consensus price target of GBX 86, indicating a potential upside of 49.93%. Given NIOX Group's higher possible upside, analysts clearly believe NIOX Group is more favorable than EKF Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

22.0% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 7.6% of NIOX Group shares are owned by institutional investors. 40.0% of EKF Diagnostics shares are owned by insiders. Comparatively, 5.1% of NIOX Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

NIOX Group beats EKF Diagnostics on 7 of the 12 factors compared between the two stocks.

How does NIOX Group compare to Creo Medical Group?

Creo Medical Group (LON:CREO) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

Creo Medical Group has a beta of 1.6212822, meaning that its share price is 62% more volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market.

NIOX Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Creo Medical Group	£6M	11.54	-£25.04M	£1.00	14.25
NIOX Group	£48.70M	4.96	£995.88M	£1.64	34.98

In the previous week, Creo Medical Group had 3 more articles in the media than NIOX Group. MarketBeat recorded 3 mentions for Creo Medical Group and 0 mentions for NIOX Group. Creo Medical Group's average media sentiment score of 1.27 beat NIOX Group's score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the media.

Company	Overall Sentiment
Creo Medical Group	Positive
NIOX Group	Neutral

Creo Medical Group presently has a consensus target price of GBX 40, suggesting a potential upside of 180.70%. NIOX Group has a consensus target price of GBX 86, suggesting a potential upside of 49.93%. Given Creo Medical Group's higher probable upside, analysts clearly believe Creo Medical Group is more favorable than NIOX Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Creo Medical Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Creo Medical Group has a net margin of 88.33% compared to NIOX Group's net margin of 14.37%. NIOX Group's return on equity of 10.14% beat Creo Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Creo Medical Group	88.33%	9.56%	-20.09%
NIOX Group	14.37%	10.14%	3.95%

44.1% of Creo Medical Group shares are held by institutional investors. Comparatively, 7.6% of NIOX Group shares are held by institutional investors. 6.9% of Creo Medical Group shares are held by insiders. Comparatively, 5.1% of NIOX Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Creo Medical Group and NIOX Group tied by winning 8 of the 16 factors compared between the two stocks.

How does NIOX Group compare to Intelligent Ultrasound Group?

Intelligent Ultrasound Group (LON:IUG) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

NIOX Group has a consensus price target of GBX 86, indicating a potential upside of 49.93%. Given NIOX Group's stronger consensus rating and higher probable upside, analysts plainly believe NIOX Group is more favorable than Intelligent Ultrasound Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Ultrasound Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Intelligent Ultrasound Group has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market.

In the previous week, Intelligent Ultrasound Group's average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.

Company	Overall Sentiment
Intelligent Ultrasound Group	Neutral
NIOX Group	Neutral

NIOX Group has higher revenue and earnings than Intelligent Ultrasound Group. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Ultrasound Group	£6.57M	0.00	-£2.27M	-£0.68	N/A
NIOX Group	£48.70M	4.96	£995.88M	£1.64	34.98

75.5% of Intelligent Ultrasound Group shares are owned by institutional investors. Comparatively, 7.6% of NIOX Group shares are owned by institutional investors. 12.8% of Intelligent Ultrasound Group shares are owned by insiders. Comparatively, 5.1% of NIOX Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

NIOX Group has a net margin of 14.37% compared to Intelligent Ultrasound Group's net margin of -23.11%. NIOX Group's return on equity of 10.14% beat Intelligent Ultrasound Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Ultrasound Group	-23.11%	-23.58%	-13.51%
NIOX Group	14.37%	10.14%	3.95%

Summary

NIOX Group beats Intelligent Ultrasound Group on 11 of the 13 factors compared between the two stocks.

How does NIOX Group compare to Novacyt?

NIOX Group (LON:NIOX) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

NIOX Group has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Novacyt has a beta of 1.105, meaning that its stock price is 11% more volatile than the broader market.

NIOX Group has a net margin of 14.37% compared to Novacyt's net margin of -103.08%. NIOX Group's return on equity of 10.14% beat Novacyt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NIOX Group	14.37%	10.14%	3.95%
Novacyt	-103.08%	-96.44%	-27.98%

NIOX Group presently has a consensus target price of GBX 86, suggesting a potential upside of 49.93%. Given NIOX Group's stronger consensus rating and higher possible upside, research analysts clearly believe NIOX Group is more favorable than Novacyt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Novacyt	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

NIOX Group has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NIOX Group	£48.70M	4.96	£995.88M	£1.64	34.98
Novacyt	£20.03M	1.27	-£36.80M	-£32.00	N/A

7.6% of NIOX Group shares are held by institutional investors. Comparatively, 10.7% of Novacyt shares are held by institutional investors. 5.1% of NIOX Group shares are held by company insiders. Comparatively, 0.4% of Novacyt shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, NIOX Group's average media sentiment score of 0.00 equaled Novacyt'saverage media sentiment score.

Company	Overall Sentiment
NIOX Group	Neutral
Novacyt	Neutral

Summary

NIOX Group beats Novacyt on 12 of the 14 factors compared between the two stocks.

Get NIOX Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NIOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NIOX vs. The Competition

Export

Metric	NIOX Group	Medical Devices Industry	Medical Sector	LON Exchange
Market Cap	£241.41M	£2.15B	£7.05B	£2.85B
Dividend Yield	2.70%	2.65%	2.68%	6.17%
P/E Ratio	34.98	14.70	27.15	368.18
Price / Sales	4.96	129.45	587.92	84,612.72
Price / Cash	11.21	15.99	29.22	27.87
Price / Book	3.18	4.62	10.75	7.49
Net Income	£995.88M	£144.75M	£3.58B	£5.89B
7 Day Performance	-2.45%	0.51%	-2.07%	-0.19%
1 Month Performance	-1.10%	1.64%	3.31%	-1.00%
1 Year Performance	-16.14%	0.18%	26.35%	61.67%

NIOX Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NIOX NIOX Group	N/A	GBX 57.36 -0.8%	GBX 86 +49.9%	-17.3%	£241.41M	£48.70M	34.98	92	Gap Up
MXCT MaxCyte	N/A	GBX 1.22 -1.2%	N/A	-43.9%	£170.11M	£32.29M	N/A	80	High Trading Volume
EKF EKF Diagnostics	N/A	GBX 26.30 flat	GBX 35 +33.1%	+1.2%	£113.16M	£51.56M	55.96	356
CREO Creo Medical Group	N/A	GBX 14.56 +2.2%	GBX 40 +174.7%	+10.7%	£71.66M	£6M	14.56	279
IUG Intelligent Ultrasound Group	N/A	N/A	N/A	N/A	£42.76M	£6.57M	N/A	65

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:NIOX) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NIOX Group (NIOX) Competitors

NIOX vs. MXCT, EKF, CREO, IUG, and NCYT

How does NIOX Group compare to MaxCyte?

Summary

How does NIOX Group compare to EKF Diagnostics?

Summary

How does NIOX Group compare to Creo Medical Group?

Summary

How does NIOX Group compare to Intelligent Ultrasound Group?

Summary

How does NIOX Group compare to Novacyt?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NIOX vs. The Competition

NIOX Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NIOX Group (NIOX) Competitors

NIOX vs. MXCT, EKF, CREO, IUG, and NCYT

How does NIOX Group compare to MaxCyte?

Which has more volatility & risk, MXCT or NIOX?

Is MXCT or NIOX more profitable?

Do insiders & institutionals believe in MXCT or NIOX?

Which has better earnings & valuation, MXCT or NIOX?

Do analysts recommend MXCT or NIOX?

Does the media prefer MXCT or NIOX?

Summary

How does NIOX Group compare to EKF Diagnostics?

Does the media prefer EKF or NIOX?

Which has higher earnings & valuation, EKF or NIOX?

Which has more risk and volatility, EKF or NIOX?

Is EKF or NIOX more profitable?

Do analysts recommend EKF or NIOX?

Do institutionals & insiders believe in EKF or NIOX?

Summary

How does NIOX Group compare to Creo Medical Group?

Which has more volatility & risk, CREO or NIOX?

Which has higher valuation & earnings, CREO or NIOX?

Does the media prefer CREO or NIOX?

Do analysts rate CREO or NIOX?

Is CREO or NIOX more profitable?

Do institutionals & insiders have more ownership in CREO or NIOX?

Summary

How does NIOX Group compare to Intelligent Ultrasound Group?

Do analysts rate IUG or NIOX?

Which has more volatility and risk, IUG or NIOX?

Does the media prefer IUG or NIOX?

Which has preferable earnings & valuation, IUG or NIOX?

Do insiders and institutionals believe in IUG or NIOX?

Is IUG or NIOX more profitable?

Summary

How does NIOX Group compare to Novacyt?

Which has more volatility and risk, NIOX or NCYT?

Is NIOX or NCYT more profitable?

Do analysts recommend NIOX or NCYT?

Which has higher valuation & earnings, NIOX or NCYT?

Do insiders and institutionals have more ownership in NIOX or NCYT?

Does the media favor NIOX or NCYT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NIOX vs. The Competition

NIOX Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools